According to the latest report by IMARC Group, titled "Hydroxychloroquine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025," the global hydroxychloroquine market witnessed strong growth during 2014-2019 and expected to experience robust growth during the next five years.

Hydroxychloroquine (HCQ) is a derivative of chloroquine with the chemical formula C18H26ClN3O. It is a chemotherapeutic agent drug that was primarily used to suppress and treat acute attacks of malaria. It is widely known to be effective against the erythrocytic forms of malarial parasites. Apart from this, it is extensively utilized for the treatment of numerous autoimmune conditions. For instance, it is used for alleviating skin problems in lupus as well as avoiding pain or swelling caused due to arthritis. It is also being employed as a possible treatment of the rapidly spreading coronavirus disease (COVID-19) due to the immunosuppressive, anti-autophagy and antimalarial properties offered by the drug.

Request Free Sample Report: https://www.imarcgroup.com/hydroxychloroquine-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Hydroxychloroquine Market 2020-2025 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Amneal Pharmaceuticals Inc., Cardinal Health Inc., Cipla Ltd., Ipca Laboratories Ltd., Laurus Labs, Lupin Limited, Mylan N.V., Novartis AG, Prasco Laboratories, Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharma, Zydus Cadila, etc.

The report has segmented the market on the basis on type, region, distribution, application,grade and administration

Breakup by Dosage Type:

  • 200 Mg
  • 300 Mg
  • 400 Mg
  • Others

Breakup by Distribution:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by Application:

  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Malaria
  • Coronavirus (COVID-19)
  • Others

Breakup by Grade:

  • USP Standards Grade
  • EP Standards Grade
  • Pharmaceutical Standards Grade
  • Others

Breakup by Route of Administration:

  • Oral
  • Intravenous

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/hydroxychloroquine-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Related Report by IMARC Group:

https://www.imarcgroup.com/fitness-app-market

https://www.imarcgroup.com/automated-fare-collection-market

https://www.imarcgroup.com/vegan-cosmetics-market

https://www.imarcgroup.com/system-integration-market

https://www.imarcgroup.com/petroleum-coke-market

https://www.imarcgroup.com/tire-pressure-monitoring-system-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: sales@imarcgroup.com